Brief: Lyell Immunopharma Inc Shares Open 10.3% Above IPO Price In Nasdaq Debut
17/06/2021 17:26
June 17 (Reuters) -
* LYELL IMMUNOPHARMA INC SHARES OPEN AT $18.75 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $17.00/SHARE
Further company coverage: LYEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma